Yahoo Web Search

  1. Free report reveals changes coming to the chip sector and the one stock could skyrocket. Zacks names stock with the greatest upside in the semiconductor industry. See it free.

  2. hl.co.uk has been visited by 10K+ users in the past month

    Buy & Sell Shares With HL - The UK's #1 Platform For Private Investors. Risk Of Loss. Trade With Hargreaves Lansdown's Award Winning Share Dealing Platform. Risk Of Loss.

  3. lawdepot.com has been visited by 100K+ users in the past month

    Experience a Better Way to Create Legal Forms. Get Started on Any Device. Simple Process. Step-by-Step Instructions on All Devices.

Search results

  1. Aug 12, 2024 · Revolution Medicines is forecast to grow earnings and revenue by 12.8% and 76.8% per annum respectively. EPS is expected to grow by 16.8% per annum. Return on equity is forecast to be -105.1% in 3 years.

  2. 2 days ago · According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Revolution Medicines is $52.92, with a high forecast of $63.00 and a low forecast of $40.00.

    • (844) 978-6257
    • 700 Saginaw Drive, Redwood City CA, 94063
    • ir@revmed.com
  3. Aug 23, 2024 · Stock Price Forecast. The 13 analysts with 12-month price forecasts for RVMD stock have an average target of 49.54, with a low estimate of 30 and a high estimate of 61. The average target predicts an increase of 13.52% from the current stock price of 43.64.

  4. Aug 23, 2024 · The 46 analysts offering price forecasts for Revolution Medicines have a median target of 40.83, with a high estimate of 71.00 and a low estimate of 23.00. The median estimate represents a...

  5. 3 days ago · Analyst Forecast. According to 13 analysts, the average rating for RVMD stock is "Strong Buy." The 12-month stock price forecast is $49.54, which is an increase of 18.52% from the latest price.

    • 7.24B
    • 742,000
    • 519.21M
    • 167.04M
  6. The aggregate market value of the common stock held by non-affiliates of the registrant as of June 30, 2020 (the last business day of the registrant’s most recently completed second fiscal quarter) was approximately $1,106,856,260, based on the closing price of the registrant’s common stock, as reported by the Nasdaq Global Select Market on ...

  7. People also ask

  8. www.sec.gov › 000095017022002297 › rvmd-2021123110-K - SEC.gov

    Dec 31, 2021 · The aggregate market value of the common stock held by non-affiliates of the registrant as of June 30, 2021 (the last business day of the registrant’s most recently completed second fiscal quarter) was approximately $ 1,956 million, based on the closing price of the registrant’s common stock, as reported by the Nasdaq Global Select Market ...

  1. People also search for